Evidence map›Paper›PMID 34122300›Full record

ArticleFrontiers in neurology2021

Levels of Fibrin Degradation Products at Admission With Acute Ischemic Stroke Correlate With the NIH Stroke Scale Score 1 h After Intravenous Thrombolysis.

Bin Zhu, Limin Zhang, Wanliang Du, Jie Yang, Yue Tian, Mingfen Wu, Tingxi Wu, Xi Ling, Yilin Liu, Xingquan Zhao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Bin ZhuDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Limin ZhangDepartment of Clinical Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wanliang DuDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jie YangState Key Laboratory of Natural Medicines, Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.
Yue TianDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Mingfen WuDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Tingxi WuDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Xi LingDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yilin LiuDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Xingquan ZhaoDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zhigang ZhaoDepartment of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeijing Tian Tan Hospital · CNChina Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute ischemic strokefibrin degradation productsNIHSS scorer-tPAthrombolysis effect

Identifiers

PMID34122300
PMCPMC8194400
OpenAlexW3172440067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.